Skip to content

Age-related emergence of behavioral deficits and amyloid pathology in the J20 mouse model of Alzheimer's disease.

Sep 2026 · Behavioural Brain Research · pp. 116490 · 0 citations · 45 references
Medicine

TL;DR

Overall, non-cognitive and working memory deficits emerge early, while spatial memory impairment and amyloid pathology dominate at later stages, in the hAPP-J20 mouse model.

Abstract

Transgenic mouse models carrying familial Alzheimer's disease mutations are widely used in preclinical research, yet phenotypic variability across age and sex can complicate experimental design and interpretation. Here, we performed an age-stratified behavioral and pathological phenotyping of the hAPP-J20 mouse model using independent cohorts of female and male mice at 3, 6, and 9 months of age (n=5-21 per group depending on the assay). Animals underwent a battery of cognitive and non-cognitive assays assessing well-being-related behaviors (nesting, splash test), locomotion and exploration (open field), anxiety-like behavior (elevated O-maze), working memory (Y-maze spontaneous alternation), and spatial learning and memory (Barnes maze). In parallel, amyloid pathology was quantified using ELISA measurements of Aβ1-40 and Aβ1-42 levels and histological assessment of hippocampal plaque burden. J20 mice exhibited early behavioral alterations detectable at 3 months, including impaired working memory, increased locomotor activity, and alterations in self-care behaviors. Spatial learning alterations were detectable from 3 months, whereas robust spatial-memory deficits became more consistently evident at later ages. Soluble and insoluble Aβ species increased progressively with age, whereas hippocampal plaque pathology was minimal at 3 months and rose markedly at 6 and 9 months. Analyses including sex as an independent factor identified endpoint-specific sex-related effects but did not support a consistent sex-specific trajectory. Overall, non-cognitive and working memory deficits emerge early, while spatial memory impairment and amyloid pathology dominate at later stages. This study provides a reference framework to guide age- and sex-appropriate experimental design in preclinical studies using the J20 model.

View source

Similar papers

Open access Oct 2026

The modulatory role of early-life experiences and sex on cognitive resilience in APP/PS1 mice over time

BACKGROUND Cognitive resilience to Alzheimer’s disease (AD) can be modelled in amyloid-expressing rodents through early handling (EH). This study investigated how EH and sex affect cognition and pathology over time. METHODS We assessed cognition (open field, object recognition test, Barnes maze) in 6- and 12-month-old...

M. Carrigan, Jeniffer Sanguino-Gómez, Melis Bayer-Var et al. · 0 citations
Open access Aug 2026

Temporal Progression of Auditory Brainstem Dysfunction and Behavioral Phenotypes in Mouse Models of Tauopathy

The divergent temporal patterns of ABR alterations across genotypes suggest that genetic context, particularly ApoE4, modulates the progression of tau-driven circuit dysfunction, highlighting ABR as a potential noninvasive biomarker for early tau-related neurodegenerative disease.

Ann M. Nguyen, Helen Lo, James Fields et al. · 0 citations
Open access Aug 2026

Impaired behavioral flexibility and coping strategy shifts in 5xFAD mice in the novel Destruction-Building Test

Introduction The assessment of early ethological markers of neurodegeneration in Alzheimer’s disease (AD) remains a pivotal task in preclinical research. This study evaluates the diagnostic potential of the “Destruction-Building Test” (DBT), a novel assay based on the innate manipulative behaviors of rodents–specifical...

E. Ahremenko, A. Andreev, K. Chaprov et al. · 0 citations
Open access Aug 2026

Metabolic Shifts Precede Cognitive Decline in the Male hAß‐KI Alzheimer's Mouse Model

The utility of this model as a valuable tool for investigating systemic risk factors related to sporadic AD, and the absence of similar differences in the females highlights the importance of considering sex as a variable in AD pathology.

Evelin Melekh, Emma L. Cook, Julia G. Stante et al. · 1 citation
Open access Sep 2026

No evidence of major integrative brain clearance impairment in an Alzheimer´s disease model of transgenic APPswe/PS1dE9 mice

The findings indicate that the APPswe/PS1dE9 mouse model does not exhibit evidence of major integrative brain clearance impairment, despite this being a hallmark of sporadic AD in humans and suggest limitations of this model for studying clearance-related mechanisms of late-onset AD should be acknowledged when planning...

L. Müller, Charlotte Köhler, T. Lindner et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.